Recently Added |View More
Baptist Health Brain & Spine Care to Host 2025 Miami Neuroscience Symposium
Baptist Health Miami Neuroscience Institute will host the 2025 Miami Neuroscience Symposium on November 6-7, 2025, at the Hilton Miami Downtown in Miami, Florida
Portable EEG Technology Accelerates Seizure Diagnosis and Care
In the critical window where every second counts, point-of-care EEG technology is fundamentally changing how clinicians detect and respond to seizure activity
Baptist Health has once again been recognized among the best healthcare providers in America and remains South Florida’s most awarded healthcare system, achieving a record 63 total awards this year and recognition in 31 different types of care.
Baptist Health Brain & Spine Care Stroke Programs Earn Recognition From 'Get With The Guidelines'
Baptist Health Brain & Spine Care Stroke Programs at nine Baptist Health hospitals have earned recognition from the American Heart Association and American Stroke Association.
Is It Parkinson’s or Something Else? A Focused Clinical Guide to Early Referral
For clinicians in primary care, geriatrics, psychiatry, or general neurology, recognizing when a presentation warrants early subspecialty referral is critical for accurate diagnosis and timely initiation of targeted therapy.
Revolutionary Technologies Are Transforming Neurosurgical Care
Long gone are the days when neurosurgeons opened large drapes and positioned mirrors to reflect light onto the surgical field. Today’s practitioners can virtually “fly” through the brain using augmented reality.
When a Mystery Illness Actually Has a Fix: New Hope for Patient with Brain Condition
NPH is most common in adults aged 60 and up, and symptoms vary from person to person. Some 800,000 Americans are living with NPH, says the Hydrocephalus Association, yet it’s estimated that 80 percent remain untreated or undiagnosed.
Transcranial Magnetic Stimulation (TMS) Gave Him His Life Back
Prefrontal TMS therapy is a noninvasive neuromodulation technique approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD) in patients whose symptoms have not responded to medications or psychotherapy.
These Scholars, generously funded by the Marcus Foundation, Inc., are now able to learn more about the causes and treatment of disorders affecting the nervous system — not only from a scientific perspective but also by examining how society ...
Team-Based Approach Tackles the Deadly Diagnosis of Glioblastoma
The multidisciplinary brain tumor team of Baptist Health Miami Cancer Institute and Baptist Health Miami Neuroscience Institute delivers advanced therapies tailored to each patient’s specific needs, balancing aggressive treatment with quality of life.
PP-007: A First-in-Class Neuroprotective Agent Moves into Phase 3 Stroke Trial
A novel investigational compound, PP-007 (PEGylated carboxyhemoglobin), is advancing to a global Phase 3 clinical trial as a potential breakthrough in the treatment of acute ischemic stroke
FIU Health Physicians to Practice Under Baptist Health as Part of FIU Clinical and Academic Alliance
Baptist Health and Florida International University (FIU) Herbert Wertheim College of Medicine have formed a strategic alliance that aims to enhance patient care, physician training and clinical research in South Florida.